Top Tech Companies (764)
Don't see your company?
Create a company profile
Award-winning clinical research organization (CRO) that delivers high-quality clinical trials through strong relationships with specialization in oncology, neurology and rare diseases.
Pharmaceutical distributors
Claritas Rx is a digital health venture that brings clarity to the challenges of specialty biopharmaceutical products in the marketplace. In today’s highly complex specialty networks, our mission is to illuminate the patient experience beyond the clinical trial. Claritas Rx leverages a proprietary technology platform and deep manufacturer expertise to automate and integrate channel, commercial, and clinical data and help biopharmaceutical companies generate actionable business insights. Our work uncovers the real-world variables impacting patient access, duration of therapy, and other metrics key to commercial success, making a real impact on patient healthcare.
Compliance Insight has a purpose - to safeguard health and wellness of all stakeholders. This includes the patient, the regulatory agency (e.g. - FDA, EMEA, etc.), the executives and the employees. Their philosophy is to provide GxP services that go beyond the regulations to compliance that makes sense. They have a set of core values: 1. Do the right thing 2. Comprehensive and systemic actions for compliance 3. Flexible and options oriented but keeping the compliance goal on target 4. Think things through and don’t act without facts but make it happen by not suffering from analysis paralysis 5. Positive attitude in everything 6. Being empathetic with all stakeholders – to seek first to understand and then to be understood What makes their team different: The skill sets of an Extraordinary Compliance Insight Colleague? Compliance Insight will specifically hire, fire, review and promote pursuant to this set of core values - as developed by the Leadership Team. Their approach is to set standards ("Codes") for everyone working for Compliance Insight to not just be a good service provider but one that is considered extraordinary! To be frank, good is their enemy! These codes encompass the entire dynamic of working for Compliance Insight and embody their core values. The Code of Commitment is to their clients - what Compliance Insight will deliver once engaged. The Code of Conduct and the Code of Ethics are for their colleagues - everyone abides by these fundamentals - from office staff to subject matter experts. Their proven process: It centers around three key steps: Align - Apply - Adapt There are three things that compose all companies - A Work System, A Work Place and A Work Force. For the "Work Force", their company utilizes a system called TACM - which stands for Train, Audit, Coach and Mentor. For the other two, "Work Place" and "Work System", they use PDSA - representing Plan - Do - Study - Act.
Delivering through technology
Better Clinical Trials through Aggregated Data and Correlative Analytics For over a decade, we have been dedicated to providing biotech, pharmaceutical, and medical device enterprises with the most innovative and complete technology solutions. Drug and medical device development has been made easier, faster and less risky thanks to our pioneering means for integrating, normalizing, reconciling and presenting through a single-user interface the aggregated data, analysis, trends and metrics of all (not just some) study-related data sources -- including investigator sites, diagnostics (labs, imaging, EEG, etc.), RTSM, patient diaries, safety, accounting, drug supply chains and any others. Placing at our fingertips real-time answers to virtually any clinical, operational, and financial question regarding your study or program. Prevail Infoworks - 211 North 13th St, Philadelphia, PA 19107-1610 - +1-267-797-2001
US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize
TargeGen, Inc. is a privately held biopharmaceutical company based in San Diego, and CA. TargeGen primarily develops small molecule kinase inhibitors for applications in oncology and inflammatory diseases.
PharmaCord connects manufacturers, patients, care teams, physicians, and payors. We help innovative therapies reach the patients they were intended for, and we provide support services that enhance the patient experience on therapy. We are not your typical reimbursement hub; we are a patient services company aligned with your strategic goals. We solve commercial challenges on behalf of life science companies through three integrated service platforms; Patient Support Services, Pharmacy Services and Manufacturer Support. Free from any conflicting ownership or business interests, our goals are the same as our life science clients – to increase access to therapy – and we will go the extra mile and customize our services to achieve this objective. Together, we can redefine patient support services. Contact us! Email: [email protected] Phone: 502-805-3400 Fax: 866-791-8193
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients
.jpeg)
.png)
At Endo, our far-reaching vision is simple: to help everyone we serve live their best life. As a specialty pharmaceutical company, we’re motivated by a strong sense of purpose to find better ways to meet unique medical needs. Our global team of passionate employees understands the importance of their work. We’re dedicated to supporting one another as we connect with communities and foster partnerships that elevate quality-of-life and bring the best treatments forward. Our uncompromising commitment results in the delivery of life-enhancing therapies. From intelligent product selection to commercialization, we strive to make a meaningful, tangible impact to help everyone live their best life. Endo has global headquarters in Malvern, Pennsylvania. Community Guidelines: 1. Be respectful. Everyone who visits our page should feel comfortable and respected. 2. If we see a comment that violates anything in the following list, it may be removed. • Comments that use profanity; personally attack or bully another individual; or are off-topic, misleading, factually inaccurate, political, spam, defamatory, discriminatory or promotional. • Comments that are excessively repetitive and/or disruptive to the community. • Comments that promote illegal activity, use copyrights or trademarks or are related to an ongoing legal matter. • Comments that appear to be medical advice. We reserve the right to remove a reply for any reason at any time. 3. Adverse Event Reporting: If we see a post about an adverse event, an Endo representative will need to contact you to find out more information to comply with regulatory guidelines. If you experience a side effect while using an Endo product, please consult your physician or pharmacist immediately. You may also report to the FDA at fda.gov/medwatch or 800-FDA-1088. Replies from other users do not necessarily reflect the views of Endo. We do not endorse content added by other users.
As a premier, independently owned CDMO with over 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with us when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer our clients tailored and versatile solutions to help them bring their products to market so they can get to the patients who need them. (Simtra is a tradename of Baxter Oncology GmbH and Baxter Pharmaceutical LLC)
Essentia Health is an integrated health system serving patients in Minnesota, Wisconsin, and North Dakota. Headquartered in Duluth, Minnesota, Essentia Health combines the strengths and talents of more than 15,000 employees, including more than 2,200 physicians and advanced practitioners, who serve our patients and communities through the mission of being called to make a healthy difference in people’s lives. Essentia Health, which includes many Catholic facilities, is guided by the values of Quality, Hospitality, Respect, Joy, Justice, Stewardship, and Teamwork. The organization lives out its mission by having a patient-centered focus at 14 hospitals, 78 clinics, six long-term care facilities, six assisted living and independent living facilities, six ambulance services, 24 retail pharmacies, and one research institute
Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : A pharmaceutical group with a strong positioning : medical and natural The second largest dermo-cosmetics laboratory in the world The second largest private French pharmaceutical group The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale Avène Klorane Ducray René Furterer A-Derma Pierre Fabre Oral Care Glytone (US) Darrow (Brasil) Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France. Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business. Pierre Fabre Group has a unique company structure. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our pipeline includes two investigational oral SYK inhibitors, entospletinib and lanraplenib, which are being developed to treat acute myeloid leukemia (AML). Together the compounds have the potential to target mutations present in more than two-thirds of patients with AML. We are also advancing an oral CDK9 inhibitor, KB-0742, to treat patients with solid tumors addicted to oncogenic transcription factor activity. KB-0742 is the first investigational medicine from our internal discovery platform to enter the clinic. Beyond these three investigational compounds, we are progressing additional discovery programs, including one focused on the MYC TRN and another focused on the AR TRN. For additional information about our community guidelines, visit: https://bit.ly/3FfcDQW.
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.
Tri Pac, Inc. is a turnkey contract development and manufacturing organization (CDMO) for aerosol, liquid, tubes, and suppository consumer goods, over-the-counter product and medical devices. Markets served include Personal Care, OTC, Medical Device, Feminine Hygiene, Sexual Health & Wellness, Household and Defense. Certifications: - ISO 13485:2016 - Med Device GMP - WHO GMP - Pharmaceutical GMP - UL Health Canada OTC - UL Retailer Certification OTC - ISO 22716:2007 - Cosmetic/ EU GMP - ISO 9001:2015 - Quality - ISO 14001: 2015 - Environmental - FDA Registered Facility - Med Device - FDA Registered Facility - OTC - EPA Registered Facility - TTB Alcohol Permit - Minority Certified Business (NMSDC) - ITAR Registered Manufacturer/ Broker - Organic Certified (NOP/ANSI) Services include: > Contract Development & Manufacturing > Aerosol | BOV | Liquid | Tube Filling > Gels | Foams | Ointments | Suppositories > Supply Chain & Inventory Management > Transfer of IP, Suitability & Methods > Regulatory Compliance > Research and Development > Validation & Stability > Quality Control & Assurance > Logistics & Fulfillment
We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt Lake City.
EVERSANA is the provider of global services to the life science industry.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
